During the past decade, General Hospital "Prim.dr. Abdulah Nakas" conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital "Prim.dr. Abdulah Nakas"" #1 sponsor was "Celgene" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "InDex Pharmaceuticals" with 1 trials sponsored and "University of Sarajevo" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital "Prim.dr. Abdulah Nakas"" #1 collaborator was "General Hospital Prim. Dr. Abdulah Nakas" with 1 trials as a collaborator, "University of Dundee" with 1 trials as a collaborator and "Wellcome Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital "Prim.dr. Abdulah Nakas"" are "Rheumatoid Arthritis" (4 trials), "Crohn Disease" (3 trials), "COVID-19" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "General Hospital "Prim.dr. Abdulah Nakas"" in a lesser frequency.

Most popular intervention types in "General Hospital "Prim.dr. Abdulah Nakas"" are "Drug" (8 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital "Prim.dr. Abdulah Nakas"" are 9 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "General Hospital "Prim.dr. Abdulah Nakas"". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in General Hospital "Prim.dr. Abdulah Nakas", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital "Prim.dr. Abdulah Nakas", 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".